Clinical Drug Investigation

ISSN: 1173-2563• JCR: CLIN DRUG INVESTAdis, Springer HealthcareNew Zealand
Visit Journal Homepage
2.7
2025 Impact Factor
2.5
5-Year Impact Factor
Q2
JCR Quartile
B3
CAS Block

Clinical Drug Investigation impact factor and JCR quartile

The 2025 impact factor for Clinical Drug Investigation is 2.7. The 5-year impact factor is 2.5. The journal is listed as JCR Q2 in the current Journal Metrics dataset.

Use this record to check the journal title, ISSN, JCR quartile, CAS block, publisher details, and similar journals before comparing publication venues.

If you searched for Clinical Drug Investigation impact factor 2025, compare this exact title record with the journal homepage and nearby journals in the same field. That helps avoid mixing this journal with a similarly named title, abbreviation, society series, or outdated metric snippet.

2025 impact factor and source check

This page is designed for exact-title searches such as Clinical Drug Investigation impact factor 2025. First confirm that the ISSN and title match this record before using the metric in a journal shortlist or submission decision.

For high-stakes submission decisions, verify the title against the publisher record at the journal homepage, Clarivate's Master Journal List or Journal Citation Reports if you have access, and the context in our methodology. Treat the 5-year impact factor, JCR quartile, article volume, and similar journals as supporting context rather than a single-number publication decision.

Journal Details

Total Articles
4,094
H-Index
80
Open Access
Hybrid
APC
$3,790 USD
Subject Areas
Cardiology and Cardiovascular MedicinePharmacologyEndocrinology, Diabetes and MetabolismPhysiologyPharmacology

Article Volume

2021
116
2022
119
2023
100
2024
79
2025
95
2026
31
Back to Search